Log in to save to my catalogue

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, reg...

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, reg...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2474171631

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

About this item

Full title

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2021, Vol.22 (1), p.98-106

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

SummaryBackgroundStereotactic ablative body radiotherapy (SABR) is increasingly being used to treat oligometastatic cancers, but high-level evidence to provide a basis for policy making is scarce. Additional evidence from a real-world setting is required. We present the results of a national study of patients with extracranial oligometastases under...

Alternative Titles

Full title

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2474171631

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2474171631

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(20)30537-4

How to access this item